Abstracts

INFLAMMATION AND DISEASE RISK AMONG HIV-SEROPOSITIVE INDIVIDUALS

Ongoing systemic inflammation contributes to increased clinical risk among contemporary HIV+ patients despite antiretroviral therapy (ART) treatment with viral suppression. This presentation will review epidemiologic data showing that blood biomarkers, reflecting generalized inflammation, innate immune response (e.g., monocyte activation), adaptive immune response (e.g., T-cell activation), and coagulation activity, predict risk for a broad spectrum of…

THE INTERSECTION OF PrEP AND SEXUALLY TRANSMITTED INFECTIONS

Bacterial sexually transmitted infections (STI) are increasing in the United States at the same time as increases in the awareness and utilization of biomedical advances in HIV treatment (TasP) and prevention (PrEP). In this environment, rates of reported new HIV infections have stabilized, and even declined in some areas. This presentation will examine a confluence…

IMPACT OF PrEP ON HIV INCIDENCE

Among persons at high risk to acquire HIV, oral PrEP has been shown to be effective, with good adherence the infection risk being reduced with 70% or more. Based on these studies PrEP is now recommended for people at substantial risk to acquire HIV. Preventing HIV among high incidence groups will potentially also have a…

FIVE CONTROVERSIES IN PrEP SCALE UP

We know that PrEP is protective and recommended for HIV prevention across populations, with good tolerability and very few safety risks. So what are the remaining controversies that are challenging us as we head towards PrEP scale-up? This talk will tackle five of the debates currently raging: (1) The potential impact of PrEP as a…

TAKING THE LEAP IN PrEP SCALE-UP: A GOOD TYPE OF CHALLENGE

The HIV prevention field finally has a highly effective biomedical intervention in oral PrEP. There has been a purposeful effort to expedite population level PrEP delivery, with different trajectories by different countries. During this session, we shall review the various strategies that guide PrEP Scale up. Walking through the journey and process taken by different…

ASSESSING HIV-1C TRANSMISSION NETWORK IN BOTSWANA AT LOW SAMPLING DENSITY

Phylodynamic assessment of HIV transmission clusters is essential for monitoring the HIV epidemic, better understanding of HIV transmission dynamics, and ultimately controlling the HIV epidemic. The phylogenetic structure of the HIV transmission network remains unknown. Near full-length HIV-1C sequences were obtained from blood specimens collected within four Botswana-Harvard AIDS Institute Partnership studies. The genotyping density…

HIV-1 GENETIC DIVERSITY AND TRANSMISSION DYNAMICS IN FISHING COMMUNITIES OF UGANDA

Although fishing communities (FCs) in Uganda are disproportionately affected by HIV-1 (prevalence of 29% and incidence of 6/100 PYAR) relative to the general population (GP), the patterns of viral transmission in this group are not completely understood to guide the implementation of targeted interventions aimed at controlling disease spread. Phylogenetic methods were used to test…

PHYLOGENETIC AND GEOGRAPHIC SEPARATION IN HIV-INFECTED PEOPLE IN BRITISH COLUMBIA

Calculating phylogenetic distances between HIV infected individuals can reveal clusters of individuals who share risk factors that may be unknown and otherwise undetected. One clear shared risk factor for infectious diseases is geographic proximity, but the relationship between phylogenetic distance and geographic distance among people with HIV is not well understood. In this study, we…

A NEW B/CRF02 CIRCULATING RECOMBINANT SPREADING QUICKLY IN PARIS AREA, FRANCE

The two majors circulating HIV-1 clades in France, subtype B and CRF02_AG, were originally present in distinct populations, Caucasian and West African population, respectively. However, CRF02_AG is increasing among all HIV populations and several recombinant forms, 7 URF and CRF56_cpx, were already identified. In this study, we describe a new B/CRF02_AG recombinant spreading quickly and…